RT Journal Article
SR Electronic
T1 External Validation of the COVID-NoLab and COVID-SimpleLab Prognostic Tools
JF The Annals of Family Medicine
JO Ann Fam Med
FD American Academy of Family Physicians
SP 548
OP 550
DO 10.1370/afm.2872
VO 20
IS 6
A1 Mark H. Ebell
A1 Robert P. Lennon
A1 Derjung M. Tarn
A1 Bruce Barrett
A1 Alex H. Krist
A1 Huamei Dong
A1 Xinyan Cai
A1 Arch G. Mainous III
A1 Aleksandra E. Zgierska
A1 Wen-Jan Tuan
A1 Munish Goyal
YR 2022
UL http://www.annfammed.org/content/20/6/548.abstract
AB Our objective was to externally validate 2 simple risk scores for mortality among a mostly inpatient population with COVID-19 in Canada (588 patients for COVID-NoLab and 479 patients for COVID-SimpleLab). The mortality rates in the low-, moderate-, and high-risk groups for COVID-NoLab were 1.1%, 9.6%, and 21.2%, respectively. The mortality rates for COVID-SimpleLab were 0.0%, 9.8%, and 20.0%, respectively. These values were similar to those in the original derivation cohort. The 2 simple risk scores, now successfully externally validated, offer clinicians a reliable way to quickly identify low-risk inpatients who could potentially be managed as outpatients in the event of a bed shortage. Both are available online (https://ebell-projects.shinyapps.io/covid_nolab/ and https://ebell-projects.shinyapps.io/COVID-SimpleLab/).